Bill > HB1044

This bill updates Pennsylvania's existing law regarding epinephrine delivery systems (previously called "auto-injectors") to provide clearer guidelines for their acquisition, storage, and use by authorized entities such as schools, camps, and other organizations. The bill revises the definition of an epinephrine delivery system to specify that it must be FDA-approved and used to prevent or treat life-threatening allergic reactions. It allows healthcare practitioners to prescribe these devices to authorized entities, and permits designated and trained employees or agents to provide or administer the device to individuals experiencing anaphylaxis, even without a prior prescription or allergy diagnosis. The bill also establishes training requirements for those who will be responsible for managing and potentially using these devices, mandating that they complete an anaphylaxis training program that covers recognizing allergic reaction symptoms, proper storage and administration procedures, and emergency follow-up steps. Additionally, the bill provides legal protections (Good Samaritan provisions) for authorized entities, healthcare practitioners, and trainers, shielding them from liability for injuries resulting from good-faith efforts to help someone during an allergic emergency, except in cases of intentional misconduct or gross negligence. The updated law will take effect 60 days after its passage.

Health and Social Services

https://www.legis.state.pa.us/cfdocs/billinfo/bill_history.cfm?syear=2025&sind=0&body=H&type=B&bn=1044